Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42574 (
caspase-3
)
45,978
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Apoptosis (programmed cell death) is an active process that plays a critical role in multiple biologic processes from embryologic development, to lymphocyte development and selection, and homeostasis. The two major mechanisms of cell death are referred to as the intrinsic and extrinsic pathways. These pathways lead to a cascade of events that ultimately converge to the activation of an effector enzyme,
caspase-3
.
Caspase-3
is a cysteine protease with aspartic specificity and a well-characterized effector of apoptosis or programmed cell death signaling. The pro-form of
caspase-3
(p32
caspase-3
) is sequestered as a zymogen, where upon proteolysis at a conserved DEVD sequence, is converted to the active (p17
caspase-3
) enzyme capable of disassembling the cell. Cell death can become disregulated under various conditions and multiple disease states (e.g., viral infection, carcinogenesis, and metastasis). Sensitive and reproducible detection of active
caspase-3
is critical to advance the understanding of cellular functions and
multiple pathologies
of various etiologies. Here, we provide two simple and reproducible methods to measure active
caspase-3
in multiple cell types and conditions using a flow cytometric-based analysis.
...
PMID:Flow cytometric detection of activated caspase-3. 1817 11
The in situ detection of
caspase-3
activity has applications in the imaging and monitoring of
multiple pathologies
, notably cancer. A series of cell penetrating FRET-based fluorogenic substrates were designed and synthesised for the detection of
caspase-3
in live cells. A variety of modifications of the classical
caspase-3
and caspase-7 substrate sequence Asp-Glu-Val-Asp were carried out in order to increase
caspase-3
affinity and eliminate caspase-7 cross-reactivity. To allow cellular uptake and good solubility, the substrates were conjugated to a cationic peptoid. The most selective fluorogenic substrate 27, FAM-Ahx-Asp-Leu-Pro-Asp-Lys(MR)-Ahx, conjugated to the cell penetrating peptoid at the C-terminus, was able to detect and quantify
caspase-3
activity in apoptotic cells without cross-reactivity by caspase-7.
...
PMID:Fluorogenic Substrates for In Situ Monitoring of Caspase-3 Activity in Live Cells. 2716 77
Mast cells (MCs) play critical roles in allergic and inflammatory reactions and contribute to
multiple pathologies
in the skin, in which they show increased numbers, which frequently correlates with severity. It remains ill-defined how MC accumulation is established by the cutaneous microenvironment, in part because research on human MCs rarely employs MCs matured in the tissue, and extrapolations from other MC subsets have limitations, considering the high level of MC heterogeneity. Thymic stromal lymphopoietin (TSLP)-released by epithelial cells, like keratinocytes, following disturbed homeostasis and inflammation-has attracted much attention, but its impact on skin MCs remains undefined, despite the vast expression of the TSLP receptor by these cells. Using several methods, each detecting a distinct component of the apoptotic process (membrane alterations, DNA degradation, and
caspase-3
activity)
,
our study pinpoints TSLP as a novel survival factor of dermal MCs. TSLP confers apoptosis resistance via concomitant activation of the TSLP/ signal transducer and activator of transcription (STAT)-5 / myeloid cell leukemia (Mcl)-1 route and a newly uncovered TSLP/ c-Jun-N-terminal kinase (JNK)/ B-cell lymphoma (Bcl)-x
L
axis, as evidenced by RNA interference and pharmacological inhibition. Our findings highlight the potential contribution of TSLP to the MC supportive niche of the skin and, vice versa, highlight MCs as crucial responders to TSLP in the context of TSLP-driven disorders.
...
PMID:Thymic Stromal Lymphopoietin Interferes with the Apoptosis of Human Skin Mast Cells by a Dual Strategy Involving STAT5/Mcl-1 and JNK/Bcl-x
L
. 3138 6